These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30301664)

  • 1. Metabolic acidosis during general anaesthesia: presumed systemic toxicity caused by topical dorzolamide in a dog.
    McFadzean WJ; Murrell J; Donaldson D
    Vet Anaesth Analg; 2018 Nov; 45(6):883-884. PubMed ID: 30301664
    [No Abstract]   [Full Text] [Related]  

  • 2. Perianesthetic metabolic acidosis is associated with 2% dorzolamide eye drops in dogs that underwent ophthalmic surgery: a retrospective study (2019-2022).
    Lim J; Lee I; Seo K; Son WG; Kang S
    J Am Vet Med Assoc; 2024 Feb; 262(2):1-9. PubMed ID: 38244267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic acidosis and anaemia associated with dorzolamide in a patient with impaired renal function.
    Hoffmanová I; Sánchez D
    Br J Clin Pharmacol; 2018 Apr; 84(4):796-799. PubMed ID: 29333622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratitis in six dogs after topical treatment with carbonic anhydrase inhibitors for glaucoma.
    Beckwith-Cohen B; Bentley E; Gasper DJ; McLellan GJ; Dubielzig RR
    J Am Vet Med Assoc; 2015 Dec; 247(12):1419-26. PubMed ID: 26642138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of topical 0.5% levobunolol alone or in association with 2% dorzolamide compared with a fixed combination of 0.5% timolol and 2% dorzolamide on intraocular pressure and heart rate in dogs without glaucoma.
    Scardillo A; Pugliese M; De Majo M; Niutta PP; Pugliese A
    Vet Ther; 2010; 11(3):E1-6. PubMed ID: 20960417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a topically administered carbonic anhydrase inhibitor (MK-927) in normotensive and glaucomatous beagles.
    King TC; Gum GG; Gelatt KN
    Am J Vet Res; 1991 Dec; 52(12):2067-70. PubMed ID: 1789524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The additive effect of topical dorzolamide and systemic acetazolamide in pediatric glaucoma.
    Sabri K; Levin AV
    J AAPOS; 2006 Oct; 10(5):464-8. PubMed ID: 17070484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of prophylactic topical carbonic anhydrase inhibitors in canine primary closed-angle glaucoma.
    Stavinohova R; Newton JR; Busse C
    J Small Anim Pract; 2015 Nov; 56(11):662-6. PubMed ID: 26334202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Trusopt--a new form of drug for treating glaucoma].
    Izdebska J
    Klin Oczna; 1997; 99(3):217-20. PubMed ID: 9456571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension.
    Gugleta K
    Curr Med Res Opin; 2010 Jun; 26(6):1255-67. PubMed ID: 20350146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythema multiforme after use of topical dorzolamide.
    Munshi V; Ahluwalia H
    J Ocul Pharmacol Ther; 2008 Feb; 24(1):91-3. PubMed ID: 18370879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Local carbonic anhydrase inhibitor dorzolamide: development and properties].
    Pfeiffer N
    Ophthalmologe; 1996 Feb; 93(1):103-18. PubMed ID: 8867167
    [No Abstract]   [Full Text] [Related]  

  • 13. Endothelial changes associated with topical dorzolamide do appear to be significant.
    Epstein RJ; Brown SV; Konowal A
    Arch Ophthalmol; 2004 Jul; 122(7):1089; author reply 1090. PubMed ID: 15249392
    [No Abstract]   [Full Text] [Related]  

  • 14. [Topical carbonic anhydrase inhibitors for glaucoma].
    Geyer O; Michaeli-Cohen A
    Harefuah; 1996 May; 130(10):705-7. PubMed ID: 8794665
    [No Abstract]   [Full Text] [Related]  

  • 15. Dorzolamide cyclodextrin nanoparticle suspension eye drops and Trusopt in rabbit.
    Jóhannesson G; Moya-Ortega MD; Asgrímsdóttir GM; Agnarsson BA; Lund SH; Loftsson T; Stefánsson E
    J Ocul Pharmacol Ther; 2014 Aug; 30(6):464-7. PubMed ID: 24734973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in topical glaucoma therapy.
    Willis AM; Diehl KA; Robbin TE
    Vet Ophthalmol; 2002 Mar; 5(1):9-17. PubMed ID: 11940242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of dorzolamide vs. pilocarpine for primary open-angle glaucoma.
    Rocchi A; Tingey D
    Can J Ophthalmol; 1997 Oct; 32(6):414-8. PubMed ID: 9363347
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical drug delivery to the eye: dorzolamide.
    Loftsson T; Jansook P; Stefánsson E
    Acta Ophthalmol; 2012 Nov; 90(7):603-8. PubMed ID: 22269010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical dorzolamide and metabolic acidosis in a neonate.
    Morris S; Geh V; Nischal KK; Sahi S; Ahmed MA
    Br J Ophthalmol; 2003 Aug; 87(8):1052-3. PubMed ID: 12881361
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of prophylactic antiglaucoma and anti-inflammatory medications in canine primary angle-closure glaucoma: a multicenter retrospective study (2004-2012).
    Dees DD; Fritz KJ; Maclaren NE; Esson DW; Sheehan Gaerig AM; Atkins RM; Knollinger AM
    Vet Ophthalmol; 2014 May; 17(3):195-200. PubMed ID: 23826812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.